Clinical Trial Update: EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating PhosLo for controlling phosphorus levels in chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• PhosLo (calcium acetate)

Snippet

Sponsor: Nabi Biopharmaceuticals | Conditions: Hyperphosphatemia, Kidney Failure | Phase 3 | Status: COMPLETED